Drugs firms have spent decades and billions of pounds in pursuit of a breakthrough drug for Alzheimer’s. Until now none has succeeded in the slowing cognitive decline and tackling the cause.Drugs firms have spent decades and billions of pounds in pursuit of a breakthrough drug for Alzheimer’s. Until now none has succeeded in the slowing cognitive decline and tackling the cause.Read MoreHealth News | Mail Online